Intrexon prices public offering of common stock

Intrexon Corporation, a leader in synthetic biology, announced that it has priced its previously announced underwritten public offering of common stock consisting of 3,750,000 shares at a public offering price of USD 27 per share. Gross proceeds to Intrexon from this offering are expected to be approximately USD 101.25 million and Intrexon intends to use the net proceeds from this offering for general corporate purposes as well as for strategic acquisitions or investments.

J.P. Morgan and BofA Merrill Lynch are acting as joint book-running managers for the offering. Jefferies is acting as a lead manager for the offering. Griffin Securities and Mizuho Securities are acting as co-managers for the offering.